In-vitro and in-vivo performance of locally manufactured glimepiride tablet generics compared to the innovator (Amaryl®) tablets.

Abou-Taleb, Basant A; Megallaa, Magdy H; Khalafallah, Nawal M; Khalil, Saleh H

In-vitro and in-vivo performance of locally manufactured glimepiride tablet generics compared to the innovator (Amaryl^®) tablets.

Abou-Taleb, Basant A; Megallaa, Magdy H; Khalafallah, Nawal M; Khalil, Saleh H.

Afiliación

Abou-Taleb BA; Department of pharmaceutics and pharmaceutical technology, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Alexandria, Egypt.
Megallaa MH; Department unit of Diabetes and Metabolism, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Khalafallah NM; Department of pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Khalil SH; Department of pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

Drug Dev Ind Pharm ; 46(2): 192-199, 2020 Feb.

Article en En | MEDLINE | ID: mdl-31937146

Asunto(s)

Medicamentos Genéricos/uso terapéutico; Hipoglucemiantes/uso terapéutico; Compuestos de Sulfonilurea/uso terapéutico; Comprimidos/uso terapéutico; Adulto; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Egipto; Femenino; Dureza; Humanos; Masculino; Persona de Mediana Edad; Solubilidad; Equivalencia Terapéutica

Palabras clave

Glimepiride; clinical study (in-vivo); generics; innovator; in vitro/in vivo correlations; pharmaceutical assessment (in-vitro); stability study

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Sulfonilurea / Comprimidos / Medicamentos Genéricos / Hipoglucemiantes Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Drug Dev Ind Pharm Año: 2020 Tipo del documento: Article País de afiliación: Egipto

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google